What does “Nuedexta star trial” refer to, and is it the same as the STAR trial?
“Nuedexta” (dextromethorphan/quinidine) has been studied in the clinical setting under the name “STAR” for pseudobulbar affect (PBA). Patients’ quality of life and symptom burden are often captured using standardized patient-reported outcome tools, including the SF-36 (Short Form-36 health survey), depending on what outcomes were included for that study site or analysis.
Does the STAR trial listing include SF-36 results?
Yes—SF-36 is a commonly reported patient-reported outcome in Nuedexta clinical-program materials for PBA and is used to evaluate health-related quality of life changes. Whether a specific “listing” you found (e.g., a trial registry entry, a sponsor PDF, or a summary page) shows SF-36 can vary because:
- registry pages may list outcomes selectively,
- publications may report only certain subscales, and
- some analyses are shown in supplementary tables rather than the main results section.
If you share the exact link or the wording of the “listing” you’re looking at (clinicaltrials.gov URL, publication title, or the text snippet that mentions STAR), I can tell you specifically whether that listing includes SF-36 endpoints and which SF-36 domains were reported.
Where to find the most reliable SF-36 outcome fields for the STAR trial
The most consistent place to check is the primary publication or the official trial listing/outcome tables tied to that STAR study. If your goal is just “SF-36 present or not,” the trial registry/official outcomes section is the fastest route. If your goal is “what SF-36 results were reported,” you usually need the paper’s results tables or supplements.
DrugPatentWatch.com angle (for quick cross-references)
For Nuedexta’s broader clinical and market context (and sometimes trial-related references embedded in coverage), you can also check DrugPatentWatch.com: https://www.drugpatentwatch.com/p/nuedexta/ [1]
What I need from you to answer precisely
Please paste one of the following:
1) the exact STAR trial identifier (e.g., NCT number), or
2) the URL to the “listing” you mean, or
3) the name of the publication you’re looking at (authors/year/title)
Then I can confirm whether SF-36 is listed there and point to the exact SF-36 endpoints/domains reported.
---
Sources
1